Our findings suggest that mitochondrial CaMKII selectively contributes to cardiac chamber dilation, potentially in acquired forms of myocardial injury with high importance to public health, and that dilated cardiomyopathy can be prevented by therapies capable of restoring mitochondrial energy metabolism. This evidence concerns the gene CAMK2G and dilated cardiomyopathy.